Detalles de la búsqueda
1.
Ibrutinib reduces obinutuzumab infusion-related reactions in patients with chronic lymphocytic leukemia and is associated with changes in plasma cytokine levels.
Haematologica
; 105(1): e22-e25, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31048356
2.
Ibrutinib plus Obinutuzumab as Frontline Therapy for Chronic Lymphocytic Leukemia Is Associated with a Lower Rate of Infusion-Related Reactions and with Sustained Remissions after Ibrutinib Discontinuation: A Single-Arm, Open-Label, Phase 1b/2 Clinical Trial NCT0231576.
Adv Hematol
; 2022: 4450824, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35103064
Resultados
1 -
2
de 2
1
Próxima >
>>